Ambit Biosciences Corp (AMBI) financial statements (2022 and earlier)

Company profile

Business Address 11080 ROSELLE STREET
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments71,189
Cash and cash equivalents71,189
Receivables1,000
Other undisclosed current assets911
Total current assets:73,100
Noncurrent Assets
Property, plant and equipment785
Restricted cash and investments63
Total noncurrent assets:848
TOTAL ASSETS:73,948
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,557
Accounts payable1,516
Accrued liabilities1,333
Employee-related liabilities1,997
Accounts payable and other accrued liabilities4,711
Other undisclosed current liabilities6,801
Total current liabilities:16,358
Noncurrent Liabilities
Total liabilities:16,358
Stockholders' equity
Stockholders' equity attributable to parent57,590
Common stock18
Additional paid in capital306,064
Accumulated other comprehensive loss(326)
Accumulated deficit(248,166)
Total stockholders' equity:57,590
TOTAL LIABILITIES AND EQUITY:73,948

Income statement (P&L) ($ in thousands)

12/31/2013
Operating expenses(34,126)
Other undisclosed operating income27,093
Operating loss:(7,033)
Nonoperating expense(4,252)
Interest and debt expense(323)
Loss from continuing operations before equity method investments, income taxes:(11,608)
Other undisclosed income from continuing operations before income taxes323
Loss from continuing operations before income taxes:(11,285)
Income tax benefit29
Net loss:(11,256)
Net income attributable to noncontrolling interest61
Net loss attributable to parent:(11,195)
Preferred stock dividends and other adjustments(3,634)
Other undisclosed net income available to common stockholders, basic1,747
Net loss available to common stockholders, diluted:(13,082)

Comprehensive Income ($ in thousands)

12/31/2013
Net loss:(11,256)
Other undisclosed comprehensive loss(373)
Comprehensive loss, net of tax, attributable to parent:(11,629)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: